p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition

M2 macrophages promote tumor progression and therapy resistance, whereas proimmunogenic M1 macrophages can contribute to the efficacy of cytostatic and immunotherapeutic strategies. The abundance of M2 macrophages in the immune infiltrate of many cancer types has prompted the search for strategies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Daniel, Drebant, Jennifer, Hägele, Tanja, Burger, Luisa, Serger, Clara, Lauenstein, Claudia, Dudys, Przemyslaw, Erdmann, Gerrit, Offringa, Rienk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292803/
https://www.ncbi.nlm.nih.gov/pubmed/34285105
http://dx.doi.org/10.1136/jitc-2020-002319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292803/
https://www.ncbi.nlm.nih.gov/pubmed/34285105
http://dx.doi.org/10.1136/jitc-2020-002319

Ejemplares similares